Startup profile · funding coverage
Metriport funding, valuation and investors
Open-source healthcare data infrastructure for point-of-care patient context and clinical AI agents.
Funding, valuation & investors
Answer-first snapshotLatest funding
Series A
$26M · August 2026
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
$26M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
series a · San Francisco, United States
Overview
Metriport builds open-source healthcare data infrastructure that aggregates patient records from health information exchanges, EHRs, labs, and pharmacies into structured context for clinicians and AI agents. Founded in 2022 and based in San Francisco, the company announced $26 million in new funding on August 27, 2026, led by Matrix general partner TJ Parker with participation from ARTIS and Y Combinator, bringing total funding to $28.4 million. Named customers include Amazon One Medical, Sollis Health, and Color Health. The company recently achieved HITRUST r2 Certification.
Why Metriport is interesting
August 2026 $26M Matrix-led raise (total $28.4M) with YC — named customers include Amazon One Medical, Sollis Health, and Color Health, with HITRUST r2 as a compliance wedge.
Product & use cases
Multi-source patient context layer for care teams and the AI agents sitting on top of clinical workflows.
- Point-of-care longitudinal chart assembly
- Care-delivery org data infrastructure
- Context supply for clinical AI agents
Key facts
- Aug 27, 2026: $26M led by Matrix; ARTIS and YC participate; total $28.4M
- Customers named: Amazon One Medical, Sollis Health, Color Health
- HITRUST r2 certified; expanding agentic AI capabilities
- Open-source health data infrastructure positioning
Funding history (newest first)
Series A
2026-08 $26M- Matrix (lead)
- ARTIS (participant)
- Y Combinator (participant)
Investors in our directory
Funds linked from Metriport's profile — open a fund page for stage focus and related deal articles.
Competitive landscape
Edge: Open-source + compliance-forward aggregation across HIEs/EHRs/labs/pharmacies rather than a single-system chart view.
Metriport competes as the context substrate for modern care delivery and clinical agents. No valuation disclosed with the August 2026 raise.
-
Legacy HIE / aggregator vendors incumbent
Established pipes with slower product cycles.
-
EHR native chart views adjacent
Sticky but fragmented across systems.
-
Clinical AI apps without owned data layer adjacent
Often depend on Metriport-class infrastructure underneath.
Notable stories
- Matrix GP TJ Parker said the best consumer-health companies he sees increasingly already work with Metriport.
- CEO Dima Goncharov framed incomplete patient history as an unacceptable default for care decisions.
Industries
Related funding articles
Venture Capital Tracker pieces that cover Metriport's financing or category context.
FAQs about Metriport
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.